222 related articles for article (PubMed ID: 22763379)
1. MLH1 methylation screening is effective in identifying epimutation carriers.
Pineda M; Mur P; Iniesta MD; Borràs E; Campos O; Vargas G; Iglesias S; Fernández A; Gruber SB; Lázaro C; Brunet J; Navarro M; Blanco I; Capellá G
Eur J Hum Genet; 2012 Dec; 20(12):1256-64. PubMed ID: 22763379
[TBL] [Abstract][Full Text] [Related]
2. De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one.
Goel A; Nguyen TP; Leung HC; Nagasaka T; Rhees J; Hotchkiss E; Arnold M; Banerji P; Koi M; Kwok CT; Packham D; Lipton L; Boland CR; Ward RL; Hitchins MP
Int J Cancer; 2011 Feb; 128(4):869-78. PubMed ID: 20473912
[TBL] [Abstract][Full Text] [Related]
3. Evidence of constitutional MLH1 epimutation associated to transgenerational inheritance of cancer susceptibility.
Crépin M; Dieu MC; Lejeune S; Escande F; Boidin D; Porchet N; Morin G; Manouvrier S; Mathieu M; Buisine MP
Hum Mutat; 2012 Jan; 33(1):180-8. PubMed ID: 21953887
[TBL] [Abstract][Full Text] [Related]
4. MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer.
Hitchins M; Williams R; Cheong K; Halani N; Lin VA; Packham D; Ku S; Buckle A; Hawkins N; Burn J; Gallinger S; Goldblatt J; Kirk J; Tomlinson I; Scott R; Spigelman A; Suter C; Martin D; Suthers G; Ward R
Gastroenterology; 2005 Nov; 129(5):1392-9. PubMed ID: 16285940
[TBL] [Abstract][Full Text] [Related]
5. MLH1 constitutional and somatic methylation in patients with MLH1 negative tumors fulfilling the revised Bethesda criteria.
Crucianelli F; Tricarico R; Turchetti D; Gorelli G; Gensini F; Sestini R; Giunti L; Pedroni M; Ponz de Leon M; Civitelli S; Genuardi M
Epigenetics; 2014 Oct; 9(10):1431-8. PubMed ID: 25437057
[TBL] [Abstract][Full Text] [Related]
6. The MLH1 c.-27C>A and c.85G>T variants are linked to dominantly inherited MLH1 epimutation and are borne on a European ancestral haplotype.
Kwok CT; Vogelaar IP; van Zelst-Stams WA; Mensenkamp AR; Ligtenberg MJ; Rapkins RW; Ward RL; Chun N; Ford JM; Ladabaum U; McKinnon WC; Greenblatt MS; Hitchins MP
Eur J Hum Genet; 2014 May; 22(5):617-24. PubMed ID: 24084575
[TBL] [Abstract][Full Text] [Related]
7. Finding the needle in a haystack: identification of cases of Lynch syndrome with MLH1 epimutation.
Hitchins MP
Fam Cancer; 2016 Jul; 15(3):413-22. PubMed ID: 26886015
[TBL] [Abstract][Full Text] [Related]
8. Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family.
Cini G; Carnevali I; Quaia M; Chiaravalli AM; Sala P; Giacomini E; Maestro R; Tibiletti MG; Viel A
Carcinogenesis; 2015 Apr; 36(4):452-8. PubMed ID: 25742745
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of MLH1 constitutional epimutations as a cause of Lynch syndrome in unselected versus selected consecutive series of patients with colorectal cancer.
Castillejo A; Hernández-Illán E; Rodriguez-Soler M; Pérez-Carbonell L; Egoavil C; Barberá VM; Castillejo MI; Guarinos C; Martínez-de-Dueñas E; Juan MJ; Sánchez-Heras AB; García-Casado Z; Ruiz-Ponte C; Brea-Fernández A; Juárez M; Bujanda L; Clofent J; Llor X; Andreu M; Castells A; Carracedo A; Alenda C; Payá A; Jover R; Soto JL
J Med Genet; 2015 Jul; 52(7):498-502. PubMed ID: 25908759
[TBL] [Abstract][Full Text] [Related]
10. Diversity of genetic events associated with MLH1 promoter methylation in Lynch syndrome families with heritable constitutional epimutation.
Leclerc J; Flament C; Lovecchio T; Delattre L; Ait Yahya E; Baert-Desurmont S; Burnichon N; Bronner M; Cabaret O; Lejeune S; Guimbaud R; Morin G; Mauillon J; Jonveaux P; Laurent-Puig P; Frébourg T; Porchet N; Buisine MP
Genet Med; 2018 Dec; 20(12):1589-1599. PubMed ID: 29790873
[TBL] [Abstract][Full Text] [Related]
11. Contribution of MLH1 constitutional methylation for Lynch syndrome diagnosis in patients with tumor MLH1 downregulation.
Pinto D; Pinto C; Guerra J; Pinheiro M; Santos R; Vedeld HM; Yohannes Z; Peixoto A; Santos C; Pinto P; Lopes P; Lothe R; Lind GE; Henrique R; Teixeira MR
Cancer Med; 2018 Feb; 7(2):433-444. PubMed ID: 29341452
[TBL] [Abstract][Full Text] [Related]
12. Identification of constitutional MLH1 epimutations and promoter variants in colorectal cancer patients from the Colon Cancer Family Registry.
Ward RL; Dobbins T; Lindor NM; Rapkins RW; Hitchins MP
Genet Med; 2013 Jan; 15(1):25-35. PubMed ID: 22878509
[TBL] [Abstract][Full Text] [Related]
13. MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study.
Gausachs M; Mur P; Corral J; Pineda M; González S; Benito L; Menéndez M; Espinàs JA; Brunet J; Iniesta MD; Gruber SB; Lázaro C; Blanco I; Capellá G
Eur J Hum Genet; 2012 Jul; 20(7):762-8. PubMed ID: 22274583
[TBL] [Abstract][Full Text] [Related]
14. Detection of allelic imbalance in MLH1 expression by pyrosequencing serves as a tool for the identification of germline defects in Lynch syndrome.
Kwok CT; Ward RL; Hawkins NJ; Hitchins MP
Fam Cancer; 2010 Sep; 9(3):345-56. PubMed ID: 20063070
[TBL] [Abstract][Full Text] [Related]
15. Highly sensitive MLH1 methylation analysis in blood identifies a cancer patient with low-level mosaic MLH1 epimutation.
Dámaso E; Canet-Hermida J; Vargas-Parra G; Velasco À; Marín F; Darder E; Del Valle J; Fernández A; Izquierdo À; Mateu G; Oliveras G; Escribano C; Piñol V; Uchima HI; Soto JL; Hitchins M; Farrés R; Lázaro C; Queralt B; Brunet J; Capellá G; Pineda M
Clin Epigenetics; 2019 Nov; 11(1):171. PubMed ID: 31779681
[TBL] [Abstract][Full Text] [Related]
16. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
[TBL] [Abstract][Full Text] [Related]
17. Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer.
Hitchins MP; Ward RL
J Med Genet; 2009 Dec; 46(12):793-802. PubMed ID: 19564652
[TBL] [Abstract][Full Text] [Related]
18. Tumour MLH1 promoter region methylation testing is an effective prescreen for Lynch Syndrome (HNPCC).
Newton K; Jorgensen NM; Wallace AJ; Buchanan DD; Lalloo F; McMahon RF; Hill J; Evans DG
J Med Genet; 2014 Dec; 51(12):789-96. PubMed ID: 25280751
[TBL] [Abstract][Full Text] [Related]
19. Identification of new cases of early-onset colorectal cancer with an MLH1 epimutation in an ethnically diverse South African cohort.
Hitchins MP; Owens SE; Kwok CT; Godsmark G; Algar UF; Ramesar RS
Clin Genet; 2011 Nov; 80(5):428-34. PubMed ID: 21375527
[TBL] [Abstract][Full Text] [Related]
20. MLH1 germline epimutations in selected patients with early-onset non-polyposis colorectal cancer.
Valle L; Carbonell P; Fernandez V; Dotor AM; Sanz M; Benitez J; Urioste M
Clin Genet; 2007 Mar; 71(3):232-7. PubMed ID: 17309645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]